The Biden administration, in its last full weekday in office, has announced the next 15 drugs up for Medicare price negotiation. Blockbuster diabetes drug Ozempic is on the list.
That means the federal government and the pharmaceuticals industry are about to go head-to-head once again. The Centers for Medicare and Medicaid Services negotiated prices for a first batch of drugs last year — something it could only do because of the Inflation Reduction Act, which passed in 2022.....MORE
